Andres Poveda, MD, discusses the results of the phase 3 SOLO2 trial in advanced ovarian cancer.
Andres Poveda, MD
Advertisement
Articles by Andres Poveda, MD
Advertisement
Latest Updated Articles
Dr. Poveda on the Results of the SOLO2 Trial in Ovarian CancerPublished: June 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5